Dual Serotonin Reuptake/5-HT1A Inhibitors (Pfizer)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameDual Serotonin Reuptake/5-HT1A Inhibitors (Pfizer)
Drug Alias NameSSRIs (Wyeth)serotonin reuptake inhibitors (Wyeth)serotonin reuptake inhibitors (Wyeth-Ayerst)WAY-426SSA-246 +[9] 
ClassificationSmall molecules
Mechanisms of ActionSerotonin 1a (5-HT1a) receptor antagonistsSerotonin reuptake inhibitors
TargetsSerotonin 1a (5-HT1a) receptorSerotonin transporter
Therapy Area/IndicationsAnxiety DisordersDepression
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesWyeth Research
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPfizer IncWyeth Research
Active IndicationsN/A
Inactive IndicationsAnxiety DisordersDepression

Other Information

ATC CodeN/A
Related LinksN/A